Biogen Has Many `Exciting' Drugs in Pipeline: CEO

Jan. 14 (Bloomberg) -- George Scangos, chief executive officer Biogen Idec Inc., talks about the company's multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Fed: Economy Expanded From Early April to Late May
07:38 - The U.S. economy expanded in the past two months, even as manufacturers in some regions took a hit from a stronger dollar and a slowdown in energy-related investment, a Fed report showed. Bloomberg's Peter Cook reports on "Bloomberg Markets." (Source: Bloomberg)
  • Analyst Crackdown Not Improving Earnings Forecasts: Study
  • How Should FIFA Manage Crisis?
  • The Best Way to Sign Off Your E-Mails